Long COVID-associated symptoms prevalent in both SARS-CoV-2 positive and negative individuals: A prospective follow-up studyOriginal Article Published on 2023-12-072024-09-05 Journal: New Microbes and New Infections [Category] update2024, [키워드] follow-up study Long COVID SARS-CoV-2 [DOI] 10.1016/j.nmni.2023.101209 PMC 바로가기 [Article Type] Original Article
Antibody response to COVID-19 vaccines among workers with a wide range of exposure to per- and polyfluoroalkyl substancesArticle Published on 2022-11-012022-11-15 Journal: Environment international [Category] 진단, [키워드] 95% CI adjusted affected analyses Analysis anti-Spike IgG antibody antigenic association coefficient comparable Concentration confidence interval Coronavirus disease 2019 COVID-19 COVID-19 antibody COVID-19 vaccination COVID-19 vaccine disease Enrollment examined follow-up study group Human IgG increase in interquartile range magnitude neutralizing antibody observation Occurrence other variables participant Perfluoroalkyl substances PFAS Polyfluoroalkyl substances recent reduced repeated measure reported response serum shown spring sulfonic acid Tetanus vaccination Vaccine vaccine-induced antibody [DOI] 10.1016/j.envint.2022.107537 PMC 바로가기
Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelaeArticle Published on 2022-10-142022-11-16 Journal: Medicina clínica [Category] COVID19(2023년), SARS, 치료기술, [키워드] age alteration alterations AUC Cardiopulmonary Covid persistente COVID-19 CPET Cuestionario de calidad de vida SF-12 detect diagnostic domain English female first positive follow-up study functional Healthcare system hospital discharge Hospitalization identify Long Long COVID maximum oxygen consumption media Patient PCR performed physical predicted primer Prospective prospectivo Prueba de esfuerzo cardiopulmonar Pruebas funcionales respiratorias pulmonary Pulmonary function Pulmonary function test Quality of life questionnaire reduced SARS-CoV-2 Sensitivity and specificity SF-12 quality of life questionnaire. significantly Spanish survivor Symptom Symptoms utility [DOI] 10.1016/j.medcli.2022.02.007 PMC 바로가기
Humoral response to SARS-CoV-2 after vaccination and booster effect in patients undergoing dialysisArticle Published on 2022-09-012022-11-15 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] administer binding antibody BNT162b2 booster Booster effect COVID-19 vaccine decrease determine dialysis Dialyzed patients domain dose evaluate follow-up study humoral Humoral response IgG IgG RBD Immunoglobulin nephropathy Patient patients postvaccination produced RBD renal replacement therapy SARS-CoV-2 SARS-CoV-2 vaccination second dose the healthy vaccination Vaccine Variation [DOI] 10.1016/j.ijid.2022.05.065 PMC 바로가기
Two-Year Health Outcomes in Hospitalized COVID-19 Survivors in ChinaArticle Published on 2022-09-012022-11-16 Journal: JAMA Network Open [Category] SARS, 변종, [키워드] 95% CI acute illness Admission age Analysis Anxiety change Chest China chronic obstructive cohort study conducted COVID-19 decrease defined discharge Dyspnea Factor fatigue Follow-up follow-up study follow-up visits Health higher risk hospital hospital discharge Hospitalization hospitalized COVID-19 identify incidence increased risk Infection intensive care IQR longitudinal cohort study male median MOST myalgia Odds ratio omicron outcome Patient patients who survived patients with COVID-19 persistence pulmonary disease questionnaire required resolved severe disease Severity of disease survivor Survivors Symptom symptom burden Symptoms total score variant virus World Health Organization worsening Wuhan, China [DOI] 10.1001/jamanetworkopen.2022.31790 PMC 바로가기
Follow-up study of anti-SARS-CoV-2 IgG antibody response in COVID-19 patients up to 6 months after infection감염 후 최대 6개월까지 COVID-19 환자에서 anti-SARS-CoV-2 IgG 항체 반응에 대한 후속 연구Article Published on 2022-09-012022-09-12 Journal: Future Microbiology [Category] MERS, SARS, 진단, [키워드] addition anti-SARS-CoV-2 IgG antibody Antibody Response Biochemical parameters Comorbidity correlated COVID-19 COVID-19 patient COVID-19 symptoms CRP D-dimer demographics determine ferritin follow-up study group Infection LDH lung involvement mechanism neutrophil count parameter participant Patient performed Protective Reinfection SARS-CoV-2 significantly higher the disease two groups urea were measured [DOI] 10.2217/fmb-2022-0006 PMC 바로가기 [Article Type] Article
Changes in life satisfaction, depression, general health and sleep quality of Spanish older women during COVID-19 lockdown and their relationship with lifestyle: an observational follow-up studyObservational Study Published on 2022-08-242022-10-04 Journal: BMJ Open [Category] SARS, 임상, [키워드] activity adherence advanced age age analysed carried center change composed COVID-19 Depression determine diet Effect Effects emotional follow-up study form geriatric medicine Health healthy Hypothesis index latency life lockdown Mental mental health Older Pain parameter physical Pittsburgh prevention protective factor Quality Quality of life questionnaire Region risk factor Satisfaction scale secondary outcome shown Sleep Sleep disturbance sleep quality Spain Spanish survey variable variables volunteers women worsening [DOI] 10.1136/bmjopen-2022-061993 PMC 바로가기 [Article Type] Observational Study
The ongoing effects of the COVID-19 pandemic on perceived physical activity, physical function and mood of older adults in the U.K: A follow-up study (March 2020-June 2021)COVID-19 대유행이 영국 노인의 인지된 신체 활동, 신체 기능 및 기분에 미치는 지속적인 영향: 후속 연구(2020년 3월-2021년 6월)Observational Study Published on 2022-08-012022-09-11 Journal: Experimental gerontology [Category] 변종, 임상, [키워드] Bayesian analysis calculation clinically conducted COVID-19 COVID-19 pandemic decrease Effect effort female Follow-up follow-up study impacted intensity interval knowledge male margin MONITOR mood observational study Older older adult Older adults participant pattern physical physical activity physical activity level physical activity levels Probability reflected Spread United Kingdom variants wild-type virus Wuhan Wuhan, China [DOI] 10.1016/j.exger.2022.111838 PMC 바로가기 [Article Type] Observational Study
Temporal trends and differences of SARS-CoV-2-specific antibody responses in symptomatic and asymptomatic subjects: a longitudinal study from Umbria in Italy증상이 있는 대상과 무증상 대상에서 SARS-CoV-2 특이 항체 반응의 시간적 경향과 차이점: 이탈리아 Umbria의 종단 연구Article Published on 2022-07-182022-09-11 Journal: BMJ Open [Category] COVID19(2023년), MERS, SARS, 진단, 치료법, [키워드] anti-S anti-S antibody antibody Antibody Response Antibody responses Antibody titre antibody titres Asymptomatic Clinical severity clinically Cohort correlation COVID-19 Decline Diagnosis discharged Dynamics eligible first visit Follow-up follow-up study group hospital Immunity immunology Infectious diseases Italy longitudinal overtime participant Participants PCR test persistence positive Protein recruited reduced Reinfection remained SARS-CoV-2 SARS-COV-2 infection serological Serological testing significant difference significantly higher Signs and symptoms spike Spike proteins subject subjects Symptom symptomatic symptomatic and asymptomatic Temporal the median three group three groups threshold titre titres Treatment two groups U/mL Variation Virology while without symptom [DOI] 10.1136/bmjopen-2021-056370 PMC 바로가기 [Article Type] Article
Protocol of the Luebeck longitudinal investigation of SARS-CoV-2 infection (ELISA) study – a prospective population-based cohort studySARS-CoV-2 감염(ELISA) 연구의 Luebeck 종단 조사 프로토콜 - 전향적 인구 기반 코호트 연구Article Published on 2022-07-072022-09-11 Journal: BMC Public Health [Category] COVID19(2023년), SARS, 변종, [키워드] ad-hoc anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies antibodies antibody approach Behavior clinical Clusters Cohort cohort-study cohorts coronavirus COVID-19 Critical cross-sectional defined Diseases Effect ELISA Factors follow-up study immunity after vaccination incidence include increased risk Infection Infectious diseases Intervention life Local measure methodological MONITOR National new SARS-CoV-2 other infectious diseases pandemic Participants PCR testing population level population-based cohort Prevalence Protective protocol Quality of life questionnaire Region risk Risk behaviors Risk factors SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 pandemic SARS-CoV-2 transmission selected Seroprevalence Spread Study protocol subset Surveillance Symptoms syndrome the SARS-CoV-2 Transmission vaccination rates variants [DOI] 10.1186/s12889-022-13666-z PMC 바로가기 [Article Type] Article